Results for tag: "Hyperphosphatemia"

Hyperphosphatemia is a condition in which there is an abnormally high level of phosphate in the blood. It is a common problem in urology and nephrology, and can be caused by a variety of factors, including kidney disease, certain medications, and dietary intake. Symptoms of hyperphosphatemia can include bone and joint pain, fatigue, and muscle weakness. Treatment typically involves dietary changes, phosphate binders, and medications to reduce phosphate levels. In the urology and nephrology market, there are a number of companies that offer products and services related to hyperphosphatemia. These include pharmaceutical companies such as Amgen, AstraZeneca, and Sanofi, as well as medical device companies such as Baxter, Fresenius Medical Care, and NxStage Medical. Additionally, there are a number of companies that specialize in providing diagnostic and therapeutic services for hyperphosphatemia, such as DiaSorin, Diazyme Laboratories, and Diazyme Diagnostics. Show Less Read more